Cogent Biosciences Files Q1 2025 10-Q
Ticker: COGT · Form: 10-Q · Filed: May 6, 2025 · CIK: 1622229
| Field | Detail |
|---|---|
| Company | Cogent Biosciences, INC. (COGT) |
| Form Type | 10-Q |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
**Cogent Biosciences Q1 2025 10-Q filed. Financials updated.**
AI Summary
Cogent Biosciences, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial status, including details on preferred stock and restricted stock units. Key dates mentioned include March 31, 2025, and December 31, 2024, with financial activities spanning the first quarter of 2025.
Why It Matters
This filing provides investors with an update on Cogent Biosciences' financial health and corporate structure as of the first quarter of 2025, crucial for understanding its operational standing.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report for a publicly traded company, indicating ongoing operations and financial reporting, but the specific financial health and future prospects are not detailed enough in this header to assess risk without further review.
Key Numbers
- 2025-03-31 — Reporting Date (End of the first quarter of 2025)
- 2024-12-31 — Previous Year End (End of fiscal year 2024)
- 2025-01-01 — Quarter Start Date (Beginning of the first quarter of 2025)
Key Players & Entities
- Cogent Biosciences, Inc. (company) — Filer
- 20250331 (date) — Period of Report
- 20250506 (date) — Filed as of Date
- Unum Therapeutics Inc. (company) — Former Company Name
- 20180402 (date) — Date of Former Company Name Change
FAQ
What was the reported period for this 10-Q filing?
The Conformed Period of Report was 20250331, indicating the period ending March 31, 2025.
What is the company's primary industry classification?
The company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
What was the company's former name?
The company was formerly known as Unum Therapeutics Inc. and Unum Therapeutics, Inc.
When did the company change its name from Unum Therapeutics Inc.?
The date of the name change from Unum Therapeutics Inc. was 20180402.
What types of preferred stock are mentioned in relation to specific dates?
The filing mentions Series B Non-Voting Convertible Preferred Stock as of 2025-03-31 and 2024-12-31, and Undesignated Preferred Stock as of 2024-12-31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding Cogent Biosciences, Inc. (COGT).